Inhibition of mast cell‐secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|64|4|1202-1216

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1202-1216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 39, Iss. 8, 2014-04 ,pp. : 873-882

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 263-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meta‐analysis of Duct‐to‐duct versus Roux‐en‐Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 4, 2015-04 ,pp. : 485-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

The innate immunity and the bile duct

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 600-608

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 188-197

John Wiley & Sons Inc

Access to resources Recommend Favorite